← All Authorities
United States enablementsection 112genus claims

Amgen Inc v Sanofi (Patent Enablement)

598 U.S. 594 (2023)
JurisdictionUnited States
CourtUnited States Supreme Court
Year2023
StatusBinding authority

Key Principle

A patent must enable the full scope of the invention; claiming by function at the genus level requires broad enablement.

Area of Law

ip

Related Cases

Warner Chappell Music Inc v Nealy 601 U.S. 366 (2024)
Vidal v Elster 602 U.S. 286 (2024)
Andy Warhol Foundation for the Visual Arts Inc v Goldsmith 598 U.S. 508 (2023)

Ask CommonBench about this case

Get a detailed analysis of Amgen Inc v Sanofi (Patent Enablement) and how it applies to your situation.

Explain Amgen Inc v Sanofi (Patent Ena...